BCHE and early-onset autosomal dominant Alzheimer disease: Similarly, cholinesterase inhibitor use was found to have uncertain clinical benefit in a recent systematic review that explored the benefits and harms of prescription drugs for the treatment of Alzheimer disease, regardless of care setting [36].